ad
This Article
Right arrow Full Version
Right arrow PDF Español
Services
Right arrow E-mail this link to a friend
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices
Right arrow Earn CME - What's This?

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

Summary of Major Changes in the 2003 Red Book

Several changes in the 2003 Red Book affect all sections of this edition. Side bar indicators have been added to facilitate easy access to the specific sections; an expanded number of Web site addresses and references to recommendations of the Committee on Infectious Diseases (COID), Committee on Pediatric AIDS, and other committees of the American Academy of Pediatrics (AAP) as well as the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) have been included; and for all tables, footnote designators have been changed from symbols to numbers for easier reference. Terms have been updated and standardized throughout the Red Book, including changing hand washing to hand hygiene, adverse reactions to adverse events, Mantoux and PPD (purified protein derivative) to tuberculin skin test, nosocomial to health care-associated, hepatitis B carrier to chronic hepatitis B virus infection; and strict isolation precautions to specific terms (contact precautions, droplet precautions, and airborne precautions). Several name changes of organisms have been incorporated throughout the book, including:

  • Pneumocystis carinii to Pneumocystis jiroveci

  • Tinea versicolor to Pityriasis versicolor

  • Norwalk virus to norovirus

  • Ehrlichia phagocytophila to Anaplasma phagocytophila

  • Chlamydia (Chlamydophila) pneumoniae

  • Chlamydia (Chlamydophila) psittaci

SECTION 1. ACTIVE AND PASSIVE IMMUNIZATION

  1. Prologue. Table 1.1 was updated to include the 2001 morbidity and percentage decrease for 9 diseases with vaccines recommended before 1990 for universal use in children in the United States.

  2. Sources of Vaccine Information. The number of sources is expanded, and Web site addresses are provided for most sources.

  3. Vaccines Produced and/or Licensed in the United States. Table 1.3 ( p 8) lists vaccines produced and/or licensed in the United States and includes a Web site for the US Food and Drug Administration that is updated regularly. Additions since . . . [Go to Full Text]